Shanghai Pharmaceuticals Holding Co., Ltd
601607
주식 순위
#2387
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
주가
$2.43
시가총액
$8.09B
변동 (1일)
-1.16%
변동 (1년)
-5.94%
국가
CN
거래 Shanghai Pharmaceuticals Holding Co., Ltd (601607)
카테고리
Healthcare
Shanghai Pharmaceuticals Holding Co., Ltd (601607)의 발행 주식 수
October 2026 기준 발행 주식 수: 0
Shanghai Pharmaceuticals Holding Co., Ltd의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 0입니다. October 2026 말 기준 회사는 0주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Shanghai Pharmaceuticals Holding Co., Ltd (601607)의 발행 주식 수 기록 (2001 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2025 | 3.71B | 0.10% |
| 2024 | 3.70B | 0.28% |
| 2023 | 3.69B | 6.07% |
| 2022 | 3.48B | 22.54% |
| 2021 | 2.84B | 0.00% |
| 2020 | 2.84B | 0.00% |
| 2019 | 2.84B | 0.45% |
| 2018 | 2.83B | 5.22% |
| 2017 | 2.69B | 0.00% |
| 2016 | 2.69B | 0.00% |
| 2015 | 2.69B | 0.00% |
| 2014 | 2.69B | 0.00% |
| 2013 | 2.69B | 0.01% |
| 2012 | 2.69B | 11.08% |
| 2011 | 2.42B | 21.48% |
| 2010 | 1.99B | 0.00% |
| 2009 | 1.99B | 249.99% |
| 2008 | 569.33M | -0.36% |
| 2007 | 571.36M | 17.21% |
| 2006 | 487.47M | 0.00% |
| 2005 | 487.47M | 0.00% |
| 2004 | 487.47M | 0.00% |
| 2003 | 487.47M | 0.00% |
| 2002 | 487.47M | 0.00% |
| 2001 | 487.47M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 118.70M | - |
US
|
|
| - | - |
US
|
|
| 236.00M | - |
US
|
|
| - | - |
US
|
|
| 11.50B | - |
AU
|
